Bristol's Breyanzi, Off To A ‘Good Start,’ Shows Efficacy In Earlier Lymphoma Setting

Bullseye
Bristol's Breyanzi succeeded in a Phase III trial in an earlier setting • Source: Alamy

More from Clinical Trials

More from R&D